Abstract: Techniques and solutions are described for facilitating the distribution of tables and table data between a shared container and one or more tenant containers. The tables can include a sharing indicator that can designate a table (or a view on a table) as having a materializable type. Materializable types can initially be deployed in the shared container, and a tenant container can have read access to the table via a view. If the tenant attempts to modify the materializable table, the table can be materialized in the tenant container. Metadata for a materializable table can include materialization instructions. Techniques and solutions are also provided for converting between sharing types, and for updating shared containers or table schemas.

Abstract: A method is provided for treating a subject in need of medication as an adjunct to elective surgery, comprising administration of a ketogenic material sufficient to produce a physiologically acceptable ketosis in tile patient. Preferably the surgery is selected from the groups consisting of removal or section of tumours, removal of redundant organs such as lymph nodes and appendix, open heart surgery, cosmetic surgery, joint and bone surgery.

Abstract: In one aspect of the invention, a needle assembly is provided, including: a body having a proximal end, a distal end, and a channel located therebetween, the body being configured to be mounted to an injector; a needle fixed to the body, the needle having proximal and distal ends, the distal end extending distally from the distal end of the body and being formed for insertion into a patient, the proximal end of the needle being in communication with the channel; and, a filter disposed in the channel proximally of the proximal end of the needle. Advantageously, a needle assembly is provided which permits mixing of at least two substances in preparation for injection, without modification to the associated injector.

Abstract: An electronic insulin delivery device receives glucose data from a glucose monitor and sets a bolus dose amount. The device may take the form of an insulin pen with automatic priming and accurate dosing provided by a motor in connection with an encoder. The device may communicate with and be controlled by a smart phone device. The smart phone device provides a user interface to receive user data including patient weight, insulin to carbohydrate ratio and exercise factor, and to send instructions to the device, including dose amount. The dose amount is determined taking into account glucose level and trend, and other factors. The delivery device may be in continuous communication with the glucose monitor and smart phone to provide for near real-time adjustments in glucose treatment. Glucose data, insulin injection data, and other relevant data may be stored and accessible to interested parties.

Abstract: A method is provided for treating a patient suffering from apoptosis of tissue comprising administering to that subject a therapeutically effective amount of one or more ketogenic compounds such that a physiological ketosis is produced sufficient to arrest said apoptosis. Preferably the apoptosis is of cerebral tissue such as that associated with acute intractible seizures, particularly with status epilepticus. The method is also applicable to apoptosis associated with administration of topic stuimuli for treatment of cancer, that produced by viral infections, autoimmune diseases or Aquired Immuno Defficiency Syndrome. The ketosis produced is a state in which levels of one or both of acetoacetate and (R)-3-hydroxybutyrate concentrations in the mood of the subject such that their total concentration in the blood is elevated above the normal fed levels to between 0.1 and 30 mM.

Abstract: A method is provided for treating a subject in need of therapy for attention deficit hyperactivity disorder (ADHD) and related CNS disorder symptoms of impaired learning, impaired planning, impaired problem solving, impulsiveness, attention deficit and aggression comprising administering to said subject an amount of a ketogenic material sufficient to produce a ketosis in the subject sufficient to provide therapeutic benefit in such behavioural disorders. Preferred materials produce a ketosis is such that the total concentration of acetoacetate and (R)-3-hydroxybutyrate in the blood of the subject is raised to between 0.1 and 30 mM.

Abstract: An electronic insulin delivery device receives glucose data from a glucose monitor and sets a bolus dose amount. The device may take the form of an insulin pen with automatic priming and accurate dosing provided by a motor in connection with an encoder. The device may communicate with and be controlled by a smart phone device. The smart phone device provides a user interface to receive user data including patient weight, insulin to carbohydrate ratio and exercise factor, and to send instructions to the device, including dose amount. The dose amount is determined taking into account glucose level and trend, and other factors. The delivery device may be in continuous communication with the glucose monitor and smart phone to provide for near real-time adjustments in glucose treatment. Glucose data, insulin injection data, and other relevant data may be stored and accessible to interested parties.

Abstract: The present invention relates to a thermoplastic composition, in particular for use in extrusion and compounding, having a continuous phase, which comprises at least one first polymer, which is selected from a group comprising a polyester, a polyesteramide, a polyesteretheramide, an aliphatic or partially aromatic polyester urethane or mixtures thereof, in particular such compounds or mixtures having hydrophobic surface properties, and at least one dispersed phase, which, as the second polymer, comprises at least one biogenic crosslinking agent having a water content of 0.1 to 30 wt. %, in particular 5 to 25 wt. %, with reference to the total weight thereof, and wherein the first polymer of the continuous phase is not miscible with the second polymer of the dispersed phase, and has at least one inorganic filler, and at least one plasticizer. The composition according to the invention is characterized in that it has the plasticizer diglycerol or mixtures with diglycerol, and the filler is in a proportion of 0.

Abstract: A valve (10) for permitting mixing of at least two components within a barrel (12) is provided including a stopper (20) configured for slidable liquid-tight engagement with an inner surface (13) of the barrel. The stopper is moveable between a first position and a second position and includes a proximal end (22), a distal end (24), and a channel (26) extending therebetween. The valve further includes a stationary body (30) comprising a base (32) and a stem (34), the stem being disposed within the channel of the stopper when the stopper is in the second position. When the stopper is in the first position, there is a liquid-tight seal in the channel, such that fluid flow through the channel is prevented. Movement of the stopper to the second position terminates the liquid-tight seal, thereby establishing fluid communication through the channel. A drug containing device and assembly for delivering a reconstituted drug are also provided herein.

Abstract: A method of level finding includes providing characteristics of a shape of a transmitted pulse in time domain launched onto a waveguide into a tank having at least one material therein, physical properties of the waveguide and real and imaginary dielectric characteristics of the material at a frequency of the pulse. A level finding algorithm having a coarse search and a fine search is implemented, where the coarse search minimizes a prediction error between an echo signal (echo curve y(k)) and a sampled pulse model echo p(k) to obtain an objective function J(k) in a vicinity of a minimum prediction error (k*). The fine search calculates at least one minimum or maximum using J(k) in the vicinity of k*. The minimum or the maximum corresponds to a level of the material or an interface involving the material.

Abstract: A method is described for providing acute symptomatic relief to a subject with Parkinson's Disease (PD) or other CNS disorders resulting from dopamine deficiency in the brain comprising administering to said subject an amount of a ketogenic material sufficient to produce a ketosis in the subject sufficient to provide therapeutic benefit in such neurological disorders. Preferred materials produce a ketosis is such that the total concentration of acetoacetate and (R)-3-hydroxybutyrate in the blood of the subject is raised to between 0.1 and 30 mM.

Abstract: The present disclosure involves systems, software, and computer implemented methods for using declarative rules for optimized access to data. One example method includes receiving a structured query language (SQL) query, the SQL query associated with at least one database table and at least one predicate. A determination is made as to whether the SQL query is associated with at least one declarative rule based on the at least one database table and the at least one predicate. In response to determining that the SQL query is associated with at least one declarative rule, the at least one associated declarative rule is applied, during optimization of the SQL query. The at least one declarative rule defines a transformation to the SQL query to be performed during query optimization. An updated SQL query is generated based on the applied at least one associated declarative rule and the updated SQL query is provided.

Abstract: A method of pulsed radar interface determination for a first and second material in a tank. An interface level determination model is provided including a transfer function that utilizes refractive indices for the materials and thickness of the second material. At least one actual radar pulse is transmitted into the tank and a resulting echo curve portion including a measured interface pulse(s) around the interface location is measured. The interface model is simulated with a reference pulse and an initial thickness value to generate an initial model generated interface pulse (initial MGIP). The measured interface pulse is compared to the initial MGIP pulse point-by-point to determine residuals. If the residuals sum >a predetermined threshold, the comparing is repeated with an updated interface model generated with an updated thickness value that provides an updated MGIP pulse. When the sum of residuals is ?predetermined threshold, the thickness is determined.

Abstract: Some embodiments of the invention include a method and system for metering an electrical grid comprising at least one processor executing instructions from a non-transitory computer-readable storage medium of an electrical grid fault detection system. In some embodiments of the system, the instructions cause a processor to calculate a prediction of whether power delivery to at least a portion of the electrical grid is functioning abnormally using voltage sensing devices coupled to at least one feeder, where one or more of the voltage sensing devices are responsive to a determination that the power delivery is functioning abnormally. Further in some embodiments, the determination includes the electrical grid fault detection system receiving at least one signal or voltage reading from the electrical grid based at least in part on a sensed or received voltage level or range of voltage level.

Abstract: A method of modeling a pulsed radar gauge (PRG) that includes a transceiver coupled by a process connection to a probe installed on a tank having at least one product material therein. A mathematical model is provided that includes (i) dielectric properties and dimensions of materials used in the process connection, (ii) at least one tank dimension, (iii) dielectric characteristics of the product material, and (iv) a probe length. Using a processor implementing a stored echo prediction algorithm that utilizes the mathematical model inputting pulse characteristics including a shape of an input radar pulse launched by a transmitter of the transceiver onto the probe into the mathematical model, and generating a predicted echo curve from the mathematical model.

Abstract: Continuous on-line thin film measurements employ a sensor having a spectrometer for interferometric measurements and a stack of single channel detectors for adsorption measurements. The stack is separated from the spectrometer, which analyzes radiation that emerges (transmitted pass or reflected from) the film, whereas the stack analyzes radiation that has passed through the film multiple times. The spectrometer is (i) positioned directly opposite the source of radiation so that it detects transmitted radiation or (ii) disposed on the same side of the film as is the source of radiation so that the spectrometer detects radiation that is specularly reflected from the film. The sensor includes a broadband radiation source emitting visible to far infrared light which propagates through a measurement cell defined by reflective surfaces exhibiting Lambertian-type scattering. The sensor is capable of measuring thin plastic films with thicknesses down to 1 micron or less.

Abstract: In one aspect of the invention, a needle assembly is provided, including: a body having a proximal end, a distal end, and a channel located therebetween, the body being configured to be mounted to an injector; a needle fixed to the body, the needle having proximal and distal ends, the distal end extending distally from the distal end of the body and being formed for insertion into a patient, the proximal end of the needle being in communication with the channel; and, a filter disposed in the channel proximally of the proximal end of the needle. Advantageously, a needle assembly is provided which permits mixing of at least two substances in preparation for injection, without modification to the associated injector.

Abstract: In one aspect of the invention, a needle assembly is provided, including: a body having a proximal end, a distal end, and a channel located therebetween, the body being configured to be mounted to an injector; a needle fixed to the body, the needle having proximal and distal ends, the distal end extending distally from the distal end of the body and being formed for insertion into a patient, the proximal end of the needle being in communication with the channel; and, a filter disposed in the channel proximally of the proximal end of the needle. Advantageously, a needle assembly is provided which permits mixing of at least two substances in preparation for injection, without modification to the associated injector.

Abstract: An electronic insulin delivery device receives glucose data from a glucose monitor and sets a bolus dose amount. The device may take the form of an insulin pen with automatic priming and accurate dosing provided by a motor in connection with an encoder. The device may communicate with and be controlled by a smart phone device. The smart phone device provides a user interface to receive user data including patient weight, insulin to carbohydrate ratio and exercise factor, and to send instructions to the device, including dose amount. The dose amount is determined taking into account glucose level and trend, and other factors. The delivery device may be in continuous communication with the glucose monitor and smart phone to provide for near real-time adjustments in glucose treatment. Glucose data, insulin injection data, and other relevant data may be stored and accessible to interested parties.

Abstract: A reverse-pull and double-down pressure bridge configuration for a stringed instrument is used to integrate a set of retrofit strings into the instrument. The retrofit strings are tethered between the bridge plate of the instrument and the back end of the instrument so that the retrofit strings are able to apply a reverse pull on a soundboard of the instrument and compress the saddle, the bridge, and the soundboard of the instrument. The retrofit strings are configured to counteract the forward pull applied on the soundboard by the original strings of the instrument.